Bayer Aktiengesellschaft Touts Pharma Turnaround at JPM Healthcare, Lifts 2025 Outlook Despite Xarelto LOE [Yahoo! Finance]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Yahoo! Finance
Morgan Healthcare Conference that the company's pharmaceutical business is showing “clear proof points” of a turnaround, pointing to updated 2025 guidance, a reshaped product portfolio following major loss-of-exclusivity headwinds, and what he described as improved R&D productivity and organizational efficiency. Oelrich referenced Bayer's results for the first nine months of 2025, saying the company upgraded its sales guidance from a range of -4% to -1% to “some slight growth,” despite experiencing what he characterized as the “full hit” of loss of exclusivity for Xarelto. He said the company also confirmed its margin goal despite losing a high-margin product, while noting currency headwinds. ? Inside D-Wave's Major Acquisition—What Changes for Investors He attributed performance primarily to growth in newer products and stability in the broader portfolio. Oelrich highlighted: Nubeqa reaching EUR 1.7 billion in the first nine months, which he called “phenomenal growth.” Kere
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Supreme Court agrees to hear longstanding fight over Roundup cancer claims [CNN]CNN
- Supreme Court agrees to hear longstanding fight over Roundup cancer claims [CNN]CNN
- A popular weedkiller is part of Supreme Court's latest case. Here's why. [USA TODAY]USA TODAY
- Genethon Signs Licensing Agreement With AskBio for the Development of an Investigational Gene Therapy for Pompe Disease [Yahoo! Finance]Yahoo! Finance
- Bayer Accelerates Pharma Growth on High-Value Portfolio [Yahoo! Finance]Yahoo! Finance